1 Calne, D.B. and Mizuno, Y. (2004) The neuromythology of Parkinson's Disease. Parkinsonism. Relat. Disord. 10: 319-22. .
2 Newman, M.E. (2003) The structure and function of complex networks. SIAM Review, 45(2): 167-256.
3 Barabasi, A.L. and Albert, R. (1999) Emergence of scaling in random networks. Science, 286 (5439), 509-512.
4 Watts, D.J. and Strogatz, S.H. (1998) Collective dynamics of 'small-world' networks. Nature. 393(6684): 440-2.
5 Agnati, L.F. and Fuxe, K. (2000) Volume transmission as a key feature of information handling in the central nervous system possible new interpretative value of the Turing's B-type machine. Prog. Brain Res. 125: 3-19.
6 Agnati, L.F., Santarossa, L., Genedani, S., Canela, E.I., Leo, G., Franco, R., Woods, A., Lluis, C., Ferrè, S. and Fuxe, K. (2004) On the nested hierarchical organization of CNS: basic characteristics of neuronal molecular networks. In: Computational Neuroscience: cortical dynamycs, Lecture Notes in Computer Sciences, Erdi P., Esposito A., Marinaro M., Scarpetta S., (Eds.), Springer, Berlin Heidelberg New York , pp. 24-54.
7 Agnati, L.F., Tarakanov, A.O., Ferrè, S. and Fuxe, K. (2005) Receptor-receptor interactions,receptor mosaics, and basic principles of molecular network organization: possibile implications for drug development. J. Mol. Neurosci. 26: 193-208.
8 Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G. et al. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507-11.
9 Stefani, M. and Dobson, C.M. (2003). Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81:678-99.
10 Stefani, M. (2004) Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim. Biophys. Acta 1739:5-25.
11.Ross, C.A. and Poirier, M.A. (2005). Opinion: What is the role of protein aggregation in neurodegeneration? Nat. Rev. Mol. Cell. Biol. 6: 891-8.
12. Dobson, C.M. (2003) Protein folding and misfolding. Nature 426: 884-90.
13. Prusiner, S.B., Scott, M., Foster, D., Pan, K.M., Groth, D., Mirenda, C., Torchia, M., Yang, S.L., Serban, D., Carlson, G.A., et al. (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell. 63(4): 673-86.
14. Kellings, K., Meyer, N., Mirenda, C., Prusiner, S.B. and Riesner, D. (1992) Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocusing gel electrophoresis. J. Gen. Virol. 73 ( Pt 4): 1025-9.
15 Chernoff, Y.O. (2004) Amyloidogenic domains, prions and structural inheritance: rudiments of early life or recent acquisition? Curr. Opin. Chem. Biol. 8:665-71.
16 Baker, D. (2000) Surprising simplicity to protein folding. Nature. 405(6782): 39-42.
17 Vendruscolo, M., Zurdo, J., MacPhee, C.E., and Dobson, C.M. (2003) Protein folding and misfolding: a paradigm of self-assembly and regulation in complex biological systems.
Philos. Transact. A. Math. Phys. Eng. Sci. 361(1807): 1205-22.
18 Hartl, F.U. and Hayer-Hartl M. (2002) Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295:1852-8.
19 Muchowski, P.J. and Wacker, J.L. (2005) Modulation of neurodegeneration by molecular chaperones. Nat. Rev. Neurosci. 6:11-22.
20 Yerbury, J.J., Stewart, E.M., Wyatt, A.R. and Wilson, M.R. (2005) Quality control of protein folding in extracellular space. EMBO, 6: 1131-6.
21 Lee, C. and Yu, M.H. (2005) Protein folding and diseases. J. Biochem. Mol. Biol. 38: 275-80.
22 Agnati, L.F., Santarossa, L., Benfenati, F., Ferri, M., Morpurgo, A., Apolloni, B. and Fuxe, K. (2002) Molecular basis of learning and memory: modelling based on receptor mosaics. In From Synapses to Rules, (eds B. Apolloni and F. Kurfes), Kluwer Academic/Plenum Publishers, New York, pp. 165-96.
23 Agnati, L.F., Ferrè, S., Lluis, C., Franco, R. and Fuxe, K. (2003) Molecular Mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol. Rev. 55: 509-50.
24 Agnati, L.F., Guidolin, D., Genedani, S., Ferré, S., Bigiani, A., Woods, A.S. and Fuxe, K. (2005) How proteins come together in the plasma membrane and function in macromolecular assemblies: focus on receptor mosaics. J. Mol. Neurosci. 26: 133-54.
25 Agnati, L.F., Leo, G., Zanardi, A., Genedani, S., Rivera, A., Fuxe, K. and Guidolin, D. (2006) Volume transmission and wiring transmission from cellular to molecular networks: history and perspectives. Acta Physiol. 187: 329-44.
26 Agnati L.F. (2006) Testo Atlante di Fisiologia Umana: Apparato Renale. CEA, Milano.
27 Evanko, D.S., Zhang, Q., Zorec, R. and Haydon, P.G. (2004) Defining pathways of loss and secretion of chemical messengers from astrocytes. Glia. 47: 233-40.
28 Monod, J., Changeux, J.P. and Jacob, F. (1963) Allosteric proteins and cellular control systems. J. Mol. Biol. 6:306-29.
29 Christopoulos, A. and Kenakin, T. (2002) G protein-coupled receptor allosterism and complexing. Pharmacol. Rev. 54: 323-74.
30 Koshland, D.E. Jr and Hamadani, K. (2002) Proteomics and models for enzyme cooperativity. J. Biol. Chem. 277:46841-4.
31 Agnati, L.F., Fuxe, K. and Ferrè S. (2005) How receptor mosaics decode transmitter signals. Possible relevance of cooperativity. Trends Biochem. Sci. 30: 188-93.
32 Agnat,i L.F., Fuxe, K., Zoli, M., Rondanini, C. and Ögren, S.O. (1982) New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram. Med. Biol. 60:183-190.
33 Agnati, L.F., Ferré, S., Leo, G., Lluis, C., Canela, E.I., Franco, R. and Fuxe K. (2004) On the Molecular Basis of the Receptor Mosaic Hypothesis of the Engram
J. Mol. Cell. Neurobiol., 24:501-516.
34 Agnati, L.F., Franzen, O., Ferré, S., Leo, G., Franco, R. and Fuxe, K. (2003) Possibile role of intramembrane receptor-receptor interactions in memory and learning via formation of long-lived heteromeric complexes: focus on motor learning in the basal ganglia. J. Neural. Transm. 65:195-222.
35 Changeux, J.P., Devillers Thiery, A. and Chemouilli, P. (1984) Acetylcholine receptor: an allosteric protein. Science 225(4668): 1335-45.
36 Unger, J.W. (1998) Glial reaction in aging and Alzheimer's Disease. Microsc. Res. Tech. 43:24-8.
37 Roher, A.E., Baudry, J., Chaney, M.O., Kuo, Y.M., Stine, W. B. and Emmerling, M.R. (2000) Oligomerization and fibril assembly of the amyloid-beta protein. Biochim. Biophys. Acta 1502: 31-43.
38 Selkoe, D.J. (2003) Aging, amyloid and Alzheimer's disease: A perspective in honor of Carl Cotman. Neurochem. Res. 28:1705-13.
39 Lee, H.G., Castellani, R.J., Zhu, X., Perry, G. and Smith, M.A. (2005) Amyloid-? in Alzheimer's disease: the horse or the cart? Pathogenetic or protective? Int. J. Exp. Path. 86:133-8.
40 Gong, Y., Chang, L., Viola, K.L., Lacor, P.N., Lambert, M.P., Finch, C.E., Krafft, G.A. and Klein, W.L. (2003) Alzheimer's disease-affected brain: Presence of oligomeric A_ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. USA 100:10417-22.
41 Lacor, P.N., Buniel, M.C., Chang, L., Fernandez, S.J., Gong, Y., Viola, K.L., Lambert, M.P., Velasco, P.T. et al. (2004) Synaptic Targeting by Alzheimer's-Related Amyloid Oligomers. J. Neurosci. 24: 10191-200.
42 Lambert, M.P., Barlow, A.K., Chromy, B.A., Edwards, C., Freed, R. Liosatos, M. Morgan, T.E., Rozovsky I. et al. (1998) Diffusible, nonfibrillar ligands derived from Ab1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95:6448-53.
43 Stephan, A., Laroche, S. and Davis, S. (2001) Generation of aggregated -amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J. Neurosci. 21: 5703-14.
44 Foguel, D. and Silva, J.L. (2004) New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies. Biochemistry 43(36): 11361-11370.
45 Seshadri, S., Beiser, A., Selhub, J., Jacques, P.F., Rosenberg, I.H., D'Agostino, R.B., Wilson, P.W. and Wolf, P.A. (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346(7): 476-83.
46 Ho, P.I., Collins, S.C., Dhitavat, S., Ortiz, D., Ashline, D., Rogers, E. and Shea, T.B. (2001) Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress. J. Neurochem. 78(2): 249-53.
47 Prusiner, S.B. (1997) Prion Diseases and the BSE Crisis. Science 278: 245-51.
48 Prusiner, S.B. (1998) Prions. Proc. Natl. Acad. Sci. U. S. A. 95(23),13363-13383
49 Campana, V., Sarnataro, D. and Zurzolo, C. (2005) The highways and byways of prion protein trafficking. Trends Cell Biol. 15(2):102-111.
50 Stahl, N., Baldwin, M.A., Teplow, D.B., Hood, L., Gibson, B.W., Burlingame, A.L. and Prusiner, S.B. (1993) Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32: 1991-2002.
51 James, T.L. Liu, H., Ulyanov, N.B., Farr-Jones, S., Zhang, H., Donne, D.G., Kaneko, K., Groth, D. et al. (1997) Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc. Natl. Acad. Sci. USA 94:10086-91.
52 DeMarco, M.L. and Daggett, V. (2005) Local environmental effects on the structure of the prion protein. C R Biologies 328:847-62.
53 Aguzzi, A. and Weissmann, C. (1997) Prion research: the next frontiers. Nature 389: 795-8.
54 Cortelli, P., Gambetti, P., Montagna, P. and Lugaresi, E. (1999) Fatal familial insomnia: clinical features and molecular genetics. J. Sleep Res. Suppl 1:23-9.
55 Carulla, N., Caddy, G.L., Hall, D.R., Zurdo, J., Gairi, M., Feliz, M., Giralt, E., Robinson, C.V. and Dobson, C.M. (2005) Molecular recycling within amyloid fibrils. Nature 436(7050): 554-8.
56 Kelly, J.V. and Balch, W.E. (2003) Amyloid as a natural product. J. Cell. Biol. 161(3), 461-2.
57 Si, K., Lindquist, S. and Kandel, E.R (2003) A neuronal isoform of the aplysia CPEB has prion-like properties. Cell 115(7), 879-91.
58 Luhrs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Dobeli, H., Schubert, D. and Riek, R. (2005) 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc. Natl. Acad. Sci. U. S. A., 102(48), 17342-7.
59 Agnati, L.F., Zunarelli, E., Genedani, S. and Fuxe, K. (2006) On the existence of a global molecular network enmeshing the whole central nervous system: physiological and pathological implications. Curr. Protein. Pept. Sci. 7(1): 3-15.
60 Van Horssen, J., Wesseling, P., van den Heuvel, L.P., de Waal, R.M. and Verbeek, M.M. (2003) Heparan sulphate proteoglycans in Alzheimer's Disease and amyloid-related disorders. Lancet Neurol. 2:482-92.
61 Paratcha, G. and Ibanez, C.F. (2002) Lipid rafts and the control of neurotrophic factor signaling in the nervous system: variations on a theme. Curr. Opin. Neurobiol. 12, 542-9.
62 Eyal, A., Szargel, R., Avraham, E., Liani, E., Haskin, J., Rott, R. and Engelender, S. (2006) Synphilin-1A: An aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from -synucleinopathy patients. Proc. Natl. Acad. Sci. USA 103:5917-22.
63 Agnati, L.F., Genedani, S., Leo, G., Forni, A., Woods, A.S., Filaferro, M. and Fuxe, K. (2006) Ab peptides as one of the crucial Volume Transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer's disease. J. Neural. Transm. In press.